Clinical Study Shows USANA Celavive's Resurfacing Serum to Improve Appearance of Skin in Just Two Weeks
Rhea-AI Summary
USANA Health Sciences has announced positive results from a clinical study of its Celavive Resurfacing Serum. The study, involving 33 women aged 39-65 with mild to moderate skin concerns, demonstrated significant skin improvements in just two weeks.
The 12-week study revealed notable improvements including:
- 15.8% reduction in fine lines appearance
- 11.6% reduction in pores appearance
- 23% reduction in acute visible hyperpigmentation
- 8.9% improvement in apparent skin clarity
- 8.6% improvement in skin radiance
The serum, containing alpha/beta hydroxy acids, niacinamide, peptides, and bakuchiol (a natural retinol alternative), was well-tolerated by all participants. Notably, 81.8% of participants reported the best skin feeling in a long time, and 97% would recommend the product.
Positive
- Clinical study demonstrates product efficacy with statistically significant results
- High customer satisfaction with 97% recommendation rate
- Product shows multiple measurable skin improvements within 12 weeks
- Company demonstrates commitment to R&D and clinical validation
Negative
- Relatively small study sample size of only 33 participants
- demographic scope focusing only on women aged 39-65
To learn more about USANA and the science behind its products, please visit USANA.com.
"We are very pleased with the results of the Resurfacing Serum clinical study, and hope this will resonate well with our customer base," said Dr. Kathryn Armstrong, USANA's chief scientific officer. "Clinical studies are the best way to show the efficacy of a product, and the outcome of this study demonstrates the high quality of our Resurfacing Serum and USANA as a whole. As a company dedicated to science and quality, USANA invests a significant amount in research and development so it is imperative we provide our customers with the most effective products possible."
The clinical study included 33 women with mild to moderate skin concerns, ranging between 39 and 65 years old with and average age of 56, and spanned different races and ethnicities.
Clinical skin measurements were taken before the participants began using Resurfacing Serum, and again after using the product for two, four, eight, and 12 weeks. The participants also completed a self-assessment questionnaire to evaluate how they felt about their skin after using the product.
Key findings of the study include:
- Visible results in as little as four weeks
- Over the 12-week course of the study, measurements showed a:
15.8% reduction in the appearance of fine lines11.6% reduction in the appearance of pores23% reduction in acute visible hyperpigmentation8.9% improvement in the apparent clarity of the skin8.6% improvement in the radiant appearance of the skin
81.8% of participants reported it was the best their skin had felt in a long time97% of participants would recommend the product
USANA's Resurfacing Serum is formulated to visibly transform the look of your skin with a powerful blend of alpha/beta hydroxy acids, niacinamide, peptides, and bakuchiol—a naturally-derived retinol alternative.
The unique combination of ingredients is unlike anything on the market in the way of efficacy and results. Upon application, it will help skin feel smoother and glowing. Long-term use will help reduce the appearance of dark spots and visible redness, while also improving fine lines and wrinkles.
About USANA
USANA (NYSE:USNA) prides itself on providing consumers with quality nutritional and lifestyle products. From its award-winning supplements to its innovative Celavive skincare and Active Nutrition lines, USANA has proven for over 30 years why it's a company you can trust. How about giving us a try? Shop at USANA.com or learn more at whatsupUSANA.com.
Media Contact:
(801) 954-7645
media(at)USANAinc(dot)com
View original content to download multimedia:https://www.prnewswire.com/news-releases/clinical-study-shows-usana-celavives-resurfacing-serum-to-improve-appearance-of-skin-in-just-two-weeks-302427190.html
SOURCE USANA